skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
MET Tyrosine Kinase Inhibitor EMD 1204831 (Code C91097)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: MET Tyrosine Kinase Inhibitor EMD 1204831

Definition: An inhibitor of the receptor tyrosine kinase Met (hepatocyte growth factor receptor) with potential antineoplastic activity. MET inhibitor EMD 1204831 selectively binds to Met tyrosine kinase, thereby disrupting MET mediated signal transduction pathways. This may induce cell death in tumor cells overexpressing this kinase. MET is overexpressed or mutated in many tumor cell types, and plays key roles in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis.

Display Name: MET Tyrosine Kinase Inhibitor EMD 1204831

Label: MET Tyrosine Kinase Inhibitor EMD 1204831

NCI Thesaurus Code: C91097 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C2984036  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
EMD 1204831
MET Tyrosine Kinase Inhibitor EMD 1204831

External Source Codes: 
PDQ Closed Trial Search ID 672542
PDQ Open Trial Search ID 672542 (check for NCI PDQ open clinical trial info)
UMLS CUI C2984036

Other Properties:
     Name Value (qualifiers indented underneath)
code C91097
Contributing_Source CTRP
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom